Quarterly report pursuant to Section 13 or 15(d)

Segment Information

v3.3.0.814
Segment Information
9 Months Ended
Sep. 30, 2015
Segment Information:  
Segment Information

Note 21 – Segment Information  

 

The Company is operating an acquisition and investment business.  Majority owned subsidiaries of 51% or more are consolidated.  The Company has determined that beginning in January 2014 there are two reportable segments, which are 1) the cannabis and medical marijuana segment which includes the receivable from Bhang of $1,500,000, the convertible note receivable and accrued interest from Electrum, and the operation of subsidiaries in the Cannabis and medical marijuana sector, and 2) the Company’s legacy investment in WCI which works with business park owners, governmental centers, and apartment complexes to reduce their trash related operating costs.  The Company also has certain small cancer related legacy investments and an investment in note receivable from a non-affiliated party that is included in the Corporate and Eliminations section below. 

 

 

Cannabis and Medical Marijuana Segment

Trash Management

Corporate unallocated and Eliminations

Consolidated

Three Months ended September 30, 2015

 

Net sales

$

33,156

$

636,107

$

-

$

669,263

Income from operations

 

7,355

11,516

(204,264)

(185,393)

Interest income

 

3,346

-

23,821

27,167

Interest expense

 

649

4,881

(1,384)

4,146

Depreciation and amortization

 

386

7,564

1,197

9,147

 

Three Months ended September 30, 2014

 

Net sales

$

1,600

$

544,615

$

-

$

546,215

Income from operations

 

(4,070)

41,646

(207,704)

(170,128)

Interest income

 

-

-

12,453

12,453

Interest expense

 

-

7,043

-

7,043

Depreciation and amortization

 

-

4,917

946

5,863

 

Nine Months ended September 30, 2015

 

Net sales

$

63,465

$

1,808,035

$

-

$

1,871,500

Income from operations

 

200

92,103

(665,134)

(572,831)

Interest income

 

5,814

-

42,040

47,854

Interest expense

 

987

14,660

(3,442)

12,205

Depreciation and amortization

 

830

21,184

2,564

24,578

 

Nine Months ended September 30, 2014

 

Net sales

$

2,550

$

1,543,578

$

-

$

1,546,128

Income from operations

 

(37,770)

154,943

(698,261)

(581,088)

Interest income

 

-

-

15,982

15,982

Interest expense

 

-

13,454

96

13,550

Depreciation and amortization

 

-

17,100

2,214

19,314

 

Total assets:

 

September 30, 2015

$

2,335,005

$

1,097,137

$

1,600,357

$

5,018,254

September 30, 2014

 

1,541,533

2,553,400

1,443,834

5,538,767

 

 

 

The following table reconciles operating segments and corporate-unallocated operating income (loss) to consolidated income before income taxes, as presented in the unaudited condensed consolidated income statements:

 

 

Three months ended

September 30

Nine months ended

September 30

 

2015

2014

2015

2014

Operating income

$

(185,393)

$

(170,128)

$

(572,831)

$

(581,088)

Gain recognized on purchase of majority interest in WCI

 

-

-

-

1,250,964

Interest income

 

27,167

12,453

47,854

15,982.00

Interest expense

 

(4,146)

(7,043)

(12,205)

(13,550)

Loan costs

 

-

-

-

(635,851)

Gain (loss) on investments

 

556

(7,782)

(2,082)

(5,590)

Gain on conversion of investment in

 

   MicroCannaBiz to note receivable

 

-

-

35,360

-

Gain (loss) on equipment disposals

 

-

(4,925)

-

(1,886)

Other income

 

-

-

-

167

 

  Income before income taxes

$

(161,816)

$

(177,425)

$

(503,904)

$

29,148